In a TSC patient with a renal AML, a missense TP53 mutation was identified in the malignant epithelioid components, but not in the typical AML components, which may suggest a role for TP53 in the malignant transformation of AML [23]. The gene discussed is TP53; the disease is acute myeloid leukemia.